Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease

BACKGROUND/AIMS: Stargardt disease is a rare, inherited, degenerative disease of the retina that is the most common type of hereditary macular dystrophy. Currently, no approved treatments for the disease exist. The purpose of this study was to characterise the pharmacodynamics of emixustat, an orall...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Ryo, Birch, David G, Gregory, Jeff K, Koester, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867285/
https://www.ncbi.nlm.nih.gov/pubmed/33214244
http://dx.doi.org/10.1136/bjophthalmol-2020-317712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867285/
https://www.ncbi.nlm.nih.gov/pubmed/33214244
http://dx.doi.org/10.1136/bjophthalmol-2020-317712

Ejemplares similares